|
Overview |
Product information |
Accredo services |
Contact team
Orfadin is indicated as an adjunct to dietary restriction of tyrosine and phenylalanine in the treatment of hereditary tyrosinemia type I.
For more information, please download the full prescribing information.
Orfadin is a registered trademark of Sweden Orphan International AB and is distributed by Rare Disease Therapeutics, Inc.
|